The global sales of disposable negative pressure wound therapy devices are estimated to be worth USD 287.5 million in 2024 and are anticipated to reach a value of USD 529.7 million by 2034. Sales are projected to rise at a CAGR of 6.3% over the forecast period between 2024 and 2034. The revenue generated by disposable negative pressure wound therapy devices in 2023 was USD 270.5 million.
The global negative pressure wound therapy (NPWT) devices market, however, has been advancing rapidly and is being positively affected by the rise of chronic illnesses such as diabetes that can lead to diabetic ulcers, pressure sores, and related other wounds. Diabetic ulcers and pressure sores tend to be the most common types of chronic wounds exhibited in the world's population, occurring in millions of individuals worldwide.
The increasing incidence and prevalence of diabetes are credited to the rise of these illnesses leading to the wound management demand. The increase in surgical procedures occurring worldwide is likewise leading to a rise of post-operative wounds, surgical site infections, etc., which is increasing the need and demand for state-of-the-art disposable NPWT wound healing solutions.
Global Disposable Negative Pressure Wound Therapy Devices Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 270.5 million |
| Estimated Size, 2024 | USD 287.5 million |
| Projected Size, 2034 | USD 529.7 million |
| Value-based CAGR (2024 to 2034) | 6.3% |
Although disposable NPWT devices are important in the treatment of low exudate, small to medium-sized wounds, NPWT therapy is applicable for vacuum-assisted wound closure techniques. This technique creates either continuous or intermittent sub-atmospheric pressure of a wound.
This pressure can enhance the recovery rate by advancing granulation tissue, minimizing edema, and drawing fluids from the wound that contains the infection. These devices are frequently used in the management of wounds secondary to surgery, traumatic wounds, pressure sores, and diabetic foot ulcers.
The increasing prevalence of chronic wounds, especially in the elderly population, is driving and will continue to drive market growth. The American Diabetes Association reported that more than 9-12 million patients in America have chronic ulcers, and 3% of the elderly aged 65 have some type of open wound.
The increasing prevalence rates and burden of chronic wounds, combined with the need for effective management of wound care, are driving the need for disposable NPWT devices. Coupled with the improving preference for disposable systems that decrease cross contamination and the need to process used devices, the adoption of disposable NPWT systems is contributing to market growth as well.
Overall, disposable NPWT devices will quickly grow during the forecast period driven by growth factors including the increased prevalence of chronic wounds, the increased aged population, and the increased promise of minimally invasive wound care products.
The technology specifically associated with this type of NPWT is improving continuously and the consumable disposable NPWT product is likely to increase multiplying demand from patients and clinicians alike.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The table below compares the compound annual growth rate (CAGR) for the global disposable negative pressure wound therapy devices market from 2023 to 2024 during the first half of the year. This overview highlights key changes and trends in revenue growth, offering valuable insights into market dynamics.
H1 covers January to June, while H2 spans July to December. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 7.4%, followed by a slightly lower growth rate of 7.0% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 7.4% (2023 to 2033) |
| H2 | 7.0% (2023 to 2033) |
| H1 | 6.3% (2024 to 2034) |
| H2 | 5.9% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 6.3% in the first half and projected to lower at 5.9% in the second half. In the first half (H1) the market witnessed a decrease of 110 BPS while in the second half (H2), the market witnessed a decrease of 110 BPS.
Rising Need for Effective Wound Care Solutions Driving NPWT Devices Market.
One of the primary drivers of growth for the NPWT devices market is the rising prevalence of chronic wounds such as VLUs, DFUs, and PUs. According to 3M, the majority of VLUs are not adequately treated with standard care, and up to 24% of DFUs lead to lower extremity amputations. This alarming statistic highlights the need for more effective wound care solutions, such as NPWT.
However, health care systems are under pressure, such as early community discharge of patients, to both reduce costs and release hospital capacity. Not all patients discharged for home care are suited for traditional powered NPWT due to the complexity of the equipment, patient compliance requirements, and the risk of bulky devices in home environments.
The costs associated with delayed wound healing are substantial, accounting for approximately 2-4% of healthcare expenditure across Europe. VLUs alone consume up to 1% of healthcare budgets, while pressure ulcers cost the UK between £1.4 to 2.2 billion annually.
DFUs and related amputations cost the NHS approximately £1 in every £120, further emphasizing the need for more efficient wound care strategies like NPWT. As healthcare providers and governments seek cost-effective solutions for chronic wounds, NPWT devices are poised to see increasing adoption.
Rising Demand and Innovations Drive Growth in the Disposable Negative Pressure Wound Therapy Devices Market
With rising advancement in patient assisted therapies, advent of new therapeutic products, the rising incidence and prevalence of diabetes leading to ulcers and sores and combined efforts of wound management companies to innovate or develop new efficient products in administration of open and chronic wounds is commanding the holistic growth of the disposable negative pressure wound therapy devices market.
The market is been propelled through developing nations such as India & Africa having increasing burden of chronic wound. Thus, all these factors are aiding to the growth of the disposable negative pressure wound therapy devices market.
For meeting the increasing demand, the key players are developing new products and are expanding geographically by enhancing their product portfolio and opening subsidiaries.
For instance, in January 2020, ConvaTec introduced ConvaMax which is a super absorber wound dressing used for the management of highly exuding wounds, including leg ulcers, pressure ulcers, diabetic foot ulcers and dehisced surgical wounds
Thus, it offers a great opportunity to the manufacturers of the disposable negative pressure wound therapy devices during the forecast years.
Increasing Trend Toward Single-Use NPWT Devices for Enhanced Skin Care
A burgeoning trend in the market is the movement toward the use of single-use devices, driven by the desire for greater comfort and ease of use for patients. These are becoming popular because they are easier to use and apply more gently, especially in patients with fragile skin.
While traditional NPWT systems are widely proven to be effective, they can potentially cause skin stripping during dressing changes or removal of the device. Conversely, single-use systems are established to prevent or minimize contact with the skin, thereby presenting a less risky option for healthcare professionals as well as for patients.
Regarding patient support, portability to aid in enhanced mobility or use in the home care setting or for patients requiring long-term wound care management is also aiding in the high adoption.
These systems are lightweight than traditional NPWT systems, and manageable by patients without constant observation or intervention by the healthcare team. The portable use also results in enhancing patient compliance with prescribed performance and increased healing.
With an ever-increasing emphasis put on patient-centered care and infection control measures, the interest and demand for single-use NPWT devices opportunities are expected to increase amongst practitioners, clinicians, and patients in the near future, which, in turn, represents broader trends in wound care that is deemed more effective and patient friendly.
Operational Challenges and Misuse of Devices Restrain Growth in the Disposable Negative Pressure Wound Therapy Devices Market
One of the primary restraints affecting the growth of the disposable negative pressure wound therapy (NPWT) devices market is operational challenges related to periwound management. Periwound complications, such as skin irritation or maceration, frequently interrupt NPWT procedures.
To mitigate these issues, healthcare providers often need to use additional measures like skin barrier wipes with each dressing change or adopt complementary therapies such as hydrocolloid dressings. These extra steps can increase the complexity of care, delay treatment, and ultimately hinder the completion of NPWT procedures.
Furthermore, patient misuse of NPWT devices is another huge obstacle. Many patients especially those who are not familiar with the technology, may take the device off too early, interrupting the continuous suction therapy that can have grave complications.
In cases where the patient does not follow the instructions, early removal of the device can lead to consequences such as infection, excessive bleeding, severe pain, and potential lethal implications such as septicemia. The risks put everyone at risk, including patients and HCPs who will have an estimated workload to deal with complications.
Because of these operational and patient-related situations, this restriction is a significant hindrance to the market because it reduces the effectiveness of the treatment and overall patient outcomes, with limitations in patient uptake and acceptance restricting the long-term market outlook of disposable NPWT devices.
Principal Consultant
The global disposable negative pressure wound therapy devices industry recorded a CAGR of 5.1% during the historical period between 2019 and 2023. The growth of disposable negative pressure wound therapy devices diagnostics industry was positive as it reached a value of USD 529.7 million in 2034 from USD 287.5 million in 2024.
Historically, negative pressure wound therapy (NPWT) devices have progressed quite well, partly due to the increase in chronic wounds across the globe including diabetic foot ulcers, venous leg ulcers, and pressure ulcers. In the past ten years of wound care technology, we have seen more advanced NPWT systems evolve and focus on patient outcomes and facilitate better healing processes and the lowering of infection rates.
Traditional NPWT devices were bulky and complex, led to hospital systems, engaged multiple disciplines of health care practitioners (HCPs), and were associated with significant burden on health care supervision.
We have seen a clear shift from NPWT therapy devices in hospital environments to portable NPWT systems developed for outpatient and homecare applications. Single-units NPWT therapy devices develop more acceptance of using these devices due to ease of use, low cost, and reduction of cross-contamination.
This has happened since Health Systems are driven in managing chronic wounds in their elderly population through efficient and cost-effective means.
Looking forward, the NPWT devices market is expected to experience robust growth, fueled by increasing incidences of diabetes and related complications such as ulcers, along with rising post-surgical wound care needs. Material science and technology, such as sensors and digital monitoring, are expected to spur innovations in NPWT devices.
In addition, increasing interest in minimally invasive therapies and homecare options will likely foster more significant adoption of portable, single-use NPWT devices, especially with manufacturers of these devices making them more cost-effective and expanding access to patients.
Tier 1 companies are the major companies as they hold a 28.5% share worldwide. These companies have large product portfolios and a high production capacity. Industries classified as Tier 1 are offering considerable investments in R&D toward the development of more sophisticated NPWT systems. Tier 1 companies include, but are by no means limited to, companies like Smith & Nephew, Cardinal Health, and 3M.
Tier 2 companies are relatively smaller as compared with tier 1 players. The tier 2 companies hold a share of 31.5% worldwide. Tier 2 manufacturers often focus on developing more affordable NPWT devices to capture price-sensitive segments of the market. This strategy allows them to compete effectively with larger players. Key Companies under this category include KCI Acelity, Mölnlycke Health Care AB and ConvaTec.
Compared to Tiers 1 and 2, Tier 3 companies offer disposable negative pressure wound therapy devices, but with smaller revenue spouts and less influence. These companies mostly operate in one or two countries and have a limited customer base. Tier 3 companies, although, smaller are essential for the market. The companies such as Lohmann & Rauscher, DeRoyal and other fall under this category.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the disposable negative pressure wound therapy devices market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America, with a CAGR of 2.0% through 2034. In Asia Pacific, India is projected to witness the highest CAGR in the market of 7.1% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 2.0% |
| Germany | 2.3% |
| India | 7.1% |
| China | 6.3% |
| South Korea | 5.0% |
The USA dominates the global market with a high share in 2023. The USA is expected to exhibit a CAGR of 2.0% throughout the forecast period (2024 to 2034).
The advance of the market for disposable negative pressure wound therapy (NPWT) devices in the USA is greatly fueled by the rising instances of open and chronic wounds particularly diabetic and foot ulcers. The easy availability and accessibility of NPWT devices have led to an increase in their usage as healthcare workers endeavor to improve the patient outcomes through the use of these devices.
The Centers for Disease Control and Prevention (CDC, 2020) provides information that roughly 4.2% of adults 18-44, 17.5% of adults 45-64, and 26.8% of adults aged 65 and older are diagnosed with diabetes, establishing a substantial population of patients who will need advanced wound care treatment.
The easy availability and accessibility of NPWT devices have increased their use as health care professionals utilize these devices to improve patient outcomes. Furthermore, increased awareness of good techniques to manage wounds unyieldingly bolster demand, alongside making NPWT devices a fundamental part of modern wound care.
In 2023, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 2.3%.
The increase in the disposable NPWT devices market in Germany is being driven primarily by the alarming increase in pressure ulcers in healthcare settings. A study conducted in 2021 showed nearly 395,980 cases of patients with at least one pressure ulcer in German hospitals.
Many of these patients had pressure ulcers that took the form of open wounds attributed to a stage greater than 2, representing over 90% of cases in healthcare. The growing incidence of pressure ulcers indicates an increasing need for effective wound management types, such as NPWT devices, to promote healing and minimize complications due to the pressure ulcer.
Additionally, the healthcare system of Germany strives to optimize patient outcomes and limiting the use of resources further fosters demand for advanced wound products. The NPWT device market will grow significantly as healthcare providers search for new devices to manage this population's burden on care.
China occupies a leading value share in East Asia market in 2023 and is expected to grow with a CAGR of 6.3% during the forecasted period.
The increase in the disposable NPWT devices market in China is being driven primarily by collaborative projects, such as the one being developed by the Chinese Tissue Repair Society (CTRS) that addresses diabetic foot ulcers.
In addition to the CTRS, this project is supported by the World Diabetes Foundation, and co-supported by Coloplast A/S, and seeks to provide improved treatment rates and increase awareness concerning effective wound management types.
Such collaborations introduce and advance the implementation of therapeutic options, and also provide education to a specialized group of healthcare professionals concerned with the management of diabetic foot ulcers.
This commitment to a meaningful health issue will foster areas of innovation within the NPWT devices development and use, while adding a potential growth to the market as a whole. Most importantly, collaboration is a foundation for the effective communication of worldwide knowledge to utilize in China's advanced wound care.
The section contains information about the leading segments in the industry. Based on product type, the disposable NPWT with canister is expected to account 68.3% of the global share in 2024.
| Product Type | Disposable NPWT with canister |
|---|---|
| Value Share (2024) | 68.3% |
By product type, disposable NPWT with canister is expected to hold a share of 38.5% in 2024.
Disposable negative pressure wound therapy is dominant (NPWT), by canisters. Managing wound closure and post-operative care remains challenging, particularly with sacrificing increasingly septic/contaminated wounds and complications around abdominal patches made scar tissue difficult to obtain primary fascial closure.
Hence, this area is expected to have the largest market share throughout the projected time frame. This is an area where there is room for advancing concerning NPWT. This is a viable treatment that has demonstrated effective wound healing and management and addresses the aforementioned clinical constraints to improve patient outcomes with comprehensive and effective wound management.
| By End User | Hospitals |
|---|---|
| Value Share (2024) | 33.8% |
Hospitals will account for 33.8% of the indication segment in 2024, and exhibit the highest CAGR in the forecast period.
Hospitals are at the forefront of the negative pressure wound therapy market, providing comprehensive care through expert clinicians who ensure patients receive thorough treatment. Within this setting, any complications or adverse events can be addressed promptly, which is a significant advantage over at-home care.
The immediate availability of medical professionals and advanced resources allows a holistic approach to wound management, ensuring that patients benefit from the best possible outcomes. This integrated care model not only enhances patient safety but also fosters a supportive environment for effective healing; making hospitals the preferred choice for negative pressure wound therapy procedures.
The market competition for disposable negative pressure wound therapy devices centers on innovation, product differentiation, cost-effectiveness, and enhanced patient outcomes. Companies are focusing on developing advanced technologies, improving ease of use, ensuring regulatory compliance, and expanding distribution channels to capture a larger market share and meet growing healthcare demands.
Recent Industry Developments in Disposable Negative Pressure Wound Therapy Devices Market
In terms of service, the industry is divided into disposable NPWT with canister and disposable NPWT without canister
In terms of end user, the industry is segregated into hospitals, clinics and home care settings
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe Middle East and Africa (MEA) have been covered in the report.
The global disposable negative pressure wound therapy devices industry is projected to witness CAGR of 6.3% between 2024 and 2034.
The global disposable negative pressure wound therapy devices industry stood at USD 270.5 million in 2023.
The global disposable negative pressure wound therapy devices industry is anticipated to reach USD 529.7 million by 2034 end.
China is expected to show a CAGR of 6.3% in the assessment period.
The key players operating in the global disposable negative pressure wound therapy devices industry include KCI Acelity; Smith & Nephew; Mölnlycke Health Care AB; Cardinal Health; ConvaTec; 3M; DeRoyal; Lohmann & Rauscher
Explore Healthcare Insights
View Reports
Disposable Negative Pressure Wound Therapy Devices Market
